FACULTY

CHAIRPERSON

CHAIRPERSON

Professor Tony Mok
Department of Clinical Oncology
The Chinese University of Hong Kong
Shatin, Hong Kong

SPEAKER

SPEAKER

Professor Haiquan Chen
Department of Thoracic Surgery
Fudan University Shanghai Cancer Center
Shanghai, China

SPEAKER

SPEAKER

Professor Enriqueta Felip
Oncology Department
Vall d’Hebron University Hospital
Barcelona, Spain

SPEAKER

SPEAKER

Professor Solange Peters
Department of Oncology
University Hospital of Lausanne
Lausanne, Switzerland

SPEAKER

SPEAKER

Professor Yi-Long Wu
Guangdong Provincial People’s Hospital
and Guangdong Lung Cancer Institute
Southern Medical University
Guangzhou, China

AGENDA

TimeTopic
14:30–14:35Opening and introduction
Professor Tony Mok
14:35–15:05Management of early-stage NSCLC with driver mutations
Professor Yi-Long Wu
15:05–16:05Debate: All resectable stage II to III NSCLC patients should be treated with neoadjuvant immunotherapies
Pro Professor Enriqueta Felip

Con: Professor Haiquan Chen
16:05–16:20Tea break
16:20–16:50Empowerment through precision: Treatment strategies for enhancing lives in ALK+ NSCLC patients
Professor Solange Peters
16:50–17:20What’s new with ICI, ADC and antibodies for lung cancer?
Professor Tony Mok
17:20–17:50Panel discussion
All speakers, moderated by Professor Tony Mok
17:50–17:55Closing remarks
Professor Tony Mok

Hong Kong CME Accreditation
The Hong Kong College of Pathologists = 3 CME points
Hong Kong College of Physicians = 3 CME points
Hong Kong College of Radiologists = 3 CME points
The College of Surgeons of Hong Kong = 3 CME points

Registration is closed.

M-XX-00015963